Epigenetic potential of histone deacetylase inhibitors in treating fibroproliferative diseases and preventing peri-implantational fibrosis
Ph.D
Saved in:
Main Author: | WANG ZHIBO |
---|---|
Other Authors: | DIVISION OF BIOENGINEERING |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/17679 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Suberoylanilide hydroxamic acid: A potential epigenetic therapeutic agent for lung fibrosis?
by: Wang, Z., et al.
Published: (2011) -
A simple and sensitive high-performance liquid chromatographic method for quantification of PXD101, a histone deacetylase inhibitor in human plasma
by: Zhang, N., et al.
Published: (2011) -
Rodent peri-implantitis models: a systematic review and meta-analysis of morphological changes
by: Chew, RJJ, et al.
Published: (2024) -
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies
by: Yong, W.P., et al.
Published: (2014) -
Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents
by: Lin, H.-S., et al.
Published: (2014)